These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 27758809)

  • 1. Dying With a Left Ventricular Assist Device as Destination Therapy.
    Dunlay SM; Strand JJ; Wordingham SE; Stulak JM; Luckhardt AJ; Swetz KM
    Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27758809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. End of Life with Left Ventricular Assist Device in Both Bridge to Transplant and Destination Therapy.
    Nakagawa S; Garan AR; Takayama H; Takeda K; Topkara VK; Yuzefpolskaya M; Lin SX; Colombo PC; Naka Y; Blinderman CD
    J Palliat Med; 2018 Sep; 21(9):1284-1289. PubMed ID: 29874117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative Medicine and Preparedness Planning for Patients Receiving Left Ventricular Assist Device as Destination Therapy-Challenges to Measuring Impact and Change in Institutional Culture.
    Verdoorn BP; Luckhardt AJ; Wordingham SE; Dunlay SM; Swetz KM
    J Pain Symptom Manage; 2017 Aug; 54(2):231-236. PubMed ID: 28093312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of End-of-Life Care in Patients Requesting Withdrawal of a Left Ventricular Assist Device Using Intranasal Opioids and Benzodiazepines.
    Wiens EJ; Pilkey J; Wong JK
    J Palliat Care; 2019 Apr; 34(2):92-95. PubMed ID: 30755087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent risk factors for ICU mortality after left ventricular assist device implantation.
    Piffard M; Nubret-Le Coniat K; Simon O; Leuillet S; Rémy A; Barandon L; Ouattara A
    Artif Organs; 2020 Feb; 44(2):153-161. PubMed ID: 31318978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bereaved Caregiver Perspectives on the End-of-Life Experience of Patients With a Left Ventricular Assist Device.
    McIlvennan CK; Jones J; Allen LA; Swetz KM; Nowels C; Matlock DD
    JAMA Intern Med; 2016 Apr; 176(4):534-9. PubMed ID: 26998594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Providing End-of-Life Care for Patients With Left Ventricular Assist Devices: Experience of a Hospice Agency.
    Pandey D; Mahmood A; Harounian J; Fleming-Damon C; Mencias M; Portenoy RK; Knotkova H
    J Pain Symptom Manage; 2021 May; 61(5):891-897. PubMed ID: 33059016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deactivation of Left Ventricular Assist Devices: Differing Perspectives of Cardiology and Hospice/Palliative Medicine Clinicians.
    McIlvennan CK; Wordingham SE; Allen LA; Matlock DD; Jones J; Dunlay SM; Swetz KM
    J Card Fail; 2017 Sep; 23(9):708-712. PubMed ID: 27932271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosocial characteristics and outcomes in patients with left ventricular assist device implanted as destination therapy.
    Snipelisky D; Stulak JM; Schettle SD; Sharma S; Kushwaha SS; Dunlay SM
    Am Heart J; 2015 Nov; 170(5):887-94. PubMed ID: 26542496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical challenges with deactivation of durable mechanical circulatory support at the end of life: left ventricular assist devices and total artificial hearts.
    Rady MY; Verheijde JL
    J Intensive Care Med; 2014; 29(1):3-12. PubMed ID: 22398630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
    Daneshmand MA; Rajagopal K; Lima B; Khorram N; Blue LJ; Lodge AJ; Hernandez AF; Rogers JG; Milano CA
    Ann Thorac Surg; 2010 Apr; 89(4):1205-9; discussion 1210. PubMed ID: 20338335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative Care Interventions before Left Ventricular Assist Device Implantation in Both Bridge to Transplant and Destination Therapy.
    Nakagawa S; Yuzefpolskaya M; Colombo PC; Naka Y; Blinderman CD
    J Palliat Med; 2017 Sep; 20(9):977-983. PubMed ID: 28504892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome in patients with end-stage heart failure who underwent continuous-flow left ventricular assist devices in a single center.
    Park Y; Kim D; Yang JH; Cho YH; Choi JO; Jeon ES
    Korean J Intern Med; 2022 Mar; 37(2):340-349. PubMed ID: 34871480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. End of life for patients with left ventricular assist devices: Insights from INTERMACS.
    McIlvennan CK; Grady KL; Matlock DD; Helmkamp LJ; Abshire M; Allen LA
    J Heart Lung Transplant; 2019 Apr; 38(4):374-381. PubMed ID: 30642799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-Ventricular Assist Device Palliative Care Consultation: A Qualitative Analysis.
    Chuzi S; Hale S; Arnold J; Zhou A; Harap R; Grady KL; Rich JD; Yancy CW; Ogunseitan A; Szmuilowicz E; Wilcox JE
    J Pain Symptom Manage; 2019 Jan; 57(1):100-107. PubMed ID: 30315917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions of Bereaved Caregivers and Clinicians About End-of-Life Care for Patients With Destination Therapy Left Ventricular Assist Devices.
    Chuzi S; Ogunseitan A; Cameron KA; Grady K; Schulze L; Wilcox JE
    J Am Heart Assoc; 2021 Aug; 10(15):e020949. PubMed ID: 34308687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ventricular assist therapy for patients with heart failure and restrictive physiology: Improving outcomes for a lethal disease.
    Grupper A; Park SJ; Pereira NL; Schettle SD; Gerber Y; Topilsky Y; Edwards BS; Daly RC; Stulak JM; Joyce LD; Kushwaha SS
    J Heart Lung Transplant; 2015 Aug; 34(8):1042-9. PubMed ID: 25940074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palliative medicine consultation for preparedness planning in patients receiving left ventricular assist devices as destination therapy.
    Swetz KM; Freeman MR; AbouEzzeddine OF; Carter KA; Boilson BA; Ottenberg AL; Park SJ; Mueller PS
    Mayo Clin Proc; 2011 Jun; 86(6):493-500. PubMed ID: 21628614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.